Aaron Kantoff's Net Worth

$1.38 Million

Estimate Recalculated Nov 1, 2024 05:48AM EST

Who is Aaron Kantoff?

Aaron Kantoff has an estimated net worth of $1.38 Million. This is based on reported shares across multiple companies, which include Centessa Pharmaceuticals plc, Tourmaline Bio, Inc., and Avalo Therapeutics, Inc..

SEC CIK

Aaron Kantoff's CIK is 0001862734

Past Insider Trading and Trends

2023 was Aaron Kantoff's most active year for acquiring shares with 4 total transactions. Aaron Kantoff's most active month to acquire stocks was the month of September. 2021 saw Aaron Kantoff paying a total of $119,850.00 for 10,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Centessa Pharmaceuticals plc (CNTA) Snapshot price: $14.3

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+20.00%
10K
$11.99
$119,850.00
60K
Nov 18
Form 3
—
0
—
—
0
No matching records found

Tourmaline Bio, Inc. (TRML) Snapshot price: $16.11

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 5
Form 4
+19.79%
7.5K
$11.86
$88,950.00
45.39K
Oct 24
Form 4
∞
37.89K
—
—
37.89K
Oct 19 - Oct 23
Form 3
—
0
—
—
0
No matching records found

Avalo Therapeutics, Inc. (AVTX) Snapshot price: $7.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 13
Form 3
—
0
—
—
0
No matching records found